No shortage on file

MIDAZOLAM INJECTION, USP

FRESENIUS KABI CANADA LTD

Quick answers

Is there a shortage of MIDAZOLAM INJECTION, USP in Canada?

No. There is no current shortage of MIDAZOLAM INJECTION, USP 1MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on file6 products

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

MIDAZOLAM INJECTION

SANDOZ CANADA INCORPORATED

1MG · DIN 02240285

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

MIDAZOLAM INJECTION BP

HOSPIRA HEALTHCARE ULC

1MG · DIN 02241753

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

VERSED INJ 1MG/ML

HOFFMANN-LA ROCHE LIMITED

1MG · DIN 00784516

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

APO-MIDAZOLAM INJECTABLE 1 MG/ML

APOTEX INC

1MG · DIN 02243253

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

VERSED INJ 5MG/ML

HOFFMANN-LA ROCHE LIMITED

5MG · DIN 00766011

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

MIDAZOLAM INJECTION, USP

FRESENIUS KABI CANADA LTD

5MG · DIN 02242905

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

METRONIDAZOLE INJECTION,USP

METRONIDAZOLE INJECTION,USP: Solution bags may be leaking in affected lots. (Updated with new lot numbers)

Type I2023-11-24

Highest health risk

Possible match — not confirmed

Metronidazole Injection, USP

Metronidazole Injection, USP: Solution bags may be leaking in affected lots

Type I2023-07-20

Highest health risk

Possible match — not confirmed

DIN

02242904

Strength

1MG

Dosage Form

Solution

Route

Intravenous Intramuscular

Active Ingredient

MIDAZOLAM

See all MIDAZOLAM products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

No shortage or discontinuation reports on file for this product.

Other Products from FRESENIUS KABI CANADA LTD

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION

900MG · DIN 02395150

2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION

20MG · DIN 02538644

5% DEXTROSE INJECTION

50MG · DIN 02403536

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02236926

ADDNUTRIV

DIN 02497697

ADENOSINE INJECTION

3MG · DIN 02457482